We are aware of current issues with the ONS login. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
Chimeric antigen receptor (CAR) T-cell therapy combines tumor-specific antigen recognition and T-cell immune fighting responses to target and destroy specific malignancies. Review this huddle card in a group or individually to learn more about chimeric antigen receptor (CAR) T -cell therapy.